Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lidak Pharm. [LDAKA] -- Ignore unavailable to you. Want to Upgrade?

To: Henry Volquardsen who wrote (756)	1/1/1998 9:47:00 AM
From: luis a. garcia	Read Replies (1) \| Respond to of 1115

Henry its new years day here and I am very surprised by the BMY news. Don't know what to make of it. I will try and find out more about it and post again later. Something does not sound kosher here. Number one Katz just added to his position in the stock. Number two I posted recently BMY got FDA approval for one of their Kaposi drugs and Lidakol is passed phase II Kaposi Sarcoma and is going into phase three. This could be a conflict of interest for BMY because they are distributing competing products. I was secretly concerned with this due to Lidakol being late. Again Lidak's Katz just hired a pr firm good with new products etc and he re-iterated the effectiveness of the drug is NOT the reaseon for BMY's dastardly move. I am going to seek out the answers and I will not make any SUDDEN moves until I know what is going on. If its dirt it will wash off clean ( first law of dirt). IF it turns out we have a problem then .... sigh.. 97 was a bad year for my stocks... luis